Welcome to our dedicated page for Revvity news (Ticker: RVTY), a resource for investors and traders seeking the latest updates and insights on Revvity stock.
Revvity Inc (NYSE: RVTY) delivers critical innovations in diagnostics and analytical solutions for healthcare, environmental safety, and industrial markets. This news hub provides investors and professionals with comprehensive updates on the company's strategic developments, regulatory milestones, and technological advancements.
Access official press releases covering product launches, research breakthroughs, financial results, and partnership announcements. Our curated collection enables informed decision-making by tracking RVTY's progress in immunodiagnostics, genomic analysis, environmental monitoring systems, and enterprise software solutions.
Key updates include developments in reproductive health technologies, contaminant detection systems, and analytical instruments for pharmaceutical quality control. Stay informed about Revvity's role in advancing food safety standards, industrial compliance solutions, and precision diagnostic tools through verified news sources.
Bookmark this page for real-time updates on RVTY's contributions to life science research and environmental health initiatives. Regularly refreshed content ensures you maintain awareness of the company's evolving position in biomedical innovation and analytical technology markets.
Revvity's Board of Directors has declared a quarterly dividend of $0.07 per share of common stock. This dividend will be paid on November 8, 2024, to shareholders of record at the close of business on October 18, 2024. Revvity, traded on the New York Stock Exchange under the ticker symbol RVTY, continues its practice of rewarding shareholders through regular dividend payments. This announcement demonstrates the company's commitment to providing consistent returns to its investors, even as it navigates the current economic landscape.
Revvity (NYSE: RVTY) will announce its Q2 2024 financial results on July 29, 2024, before the market opens. A conference call hosted by CEO Prahlad Singh and CFO Max Krakowiak will follow at 8:00 a.m. ET to discuss the results. Investors can access the live audio webcast via the company's website.
Revvity (NYSE: RVTY) will present at the 45th Annual Goldman Sachs Global Healthcare Conference on June 10, 2024, at 8:00 a.m. ET in Miami, FL. The event will feature Prahlad Singh, the president and CEO of Revvity, who will provide an update on the company's strategic priorities. A live audio webcast and a replay of the presentation will be available on the company's website.
FAQ
What is the current stock price of Revvity (RVTY)?
What is the market cap of Revvity (RVTY)?
